Therapeutic Window for Intravenous Human Muse Cell Administration in Mouse Spinal Cord Injury
International Journal of Molecular Sciences · 12.07.2026 · 27 (14) · 6219
DOI: 10.3390/ijms27146219 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.07.2026. Verfasst von Kotaro Sakashita und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Insurance Association of Japan, AO Spine National Research Grant, JST SPRING.
Abstract (Originalsprache)
Stage-specific embryonic antigen-3-positive pluripotent-like/macrophage-like multilineage-differentiating stress-enduring (Muse) cells are a distinct subpopulation of mesenchymal stromal cells (MSCs), accounting for 1% to several percent of MSCs. Although stem cell therapy for spinal cord injury (SCI) typically targets the subacute phase to avoid the hostile acute environment, the therapeutic window for Muse cells remains unclear. C57BL/6J mice with severe T9 contusion SCI received a single tail vein injection of human bone marrow-derived (BM) Muse cells, BM-MSCs (both 5 × 104 cells), or vehicle at 2, 8, 14, or 28 days post-injury (DPI) without immunosuppressants. Among the different administration time points, the 2-DPI Muse cell group exhibited significantly higher Basso Mouse Scale scores than the BM-MSC and vehicle groups from 14 days after injection, while no significant differences were observed at the other administration time points. The 2-DPI Muse cell group showed significantly greater homing to the injured spinal cord than the BM-MSC group, with persistent engraftment and neural-lineage marker expression at day 42. Ablation of engrafted Muse cells at day 42 partially reversed locomotor recovery, suggesting that engrafted Muse cells contributed to functional recovery. These findings suggest that intravenous Muse cell therapy exerts timing-dependent therapeutic effects after SCI, with greater efficacy during the early post-injury phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
- Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Miyagi, Japan.
- Department of Biochemistry, Dokkyo Medical University School of Medicine, Mibu 321-0293, Tochigi, Japan.
ORCID-Profile: Kotaro Sakashita, Shun Okuwaki, Takahiro Sunami, Hiroshi Noguchi, Masashi Yamazaki
Förderung
- General Insurance Association of Japan
- AO Spine National Research Grant
- JST SPRING
- Japan Society for the Promotion of Science
Zitieren
APA
Sakashita, K., Kushida, Y., Wakao, S., Takahashi, H., Horibata, Y., Okuwaki, S., Ogata, Y., Nakagawa, T., Sunami, T., Gamada, H., Shimizu, T., Funayama, T., Miura, K., Noguchi, H., Sugimoto, H., Yamazaki, M., Dezawa, M., & Koda, M. (2026). Therapeutic Window for Intravenous Human Muse Cell Administration in Mouse Spinal Cord Injury. International Journal of Molecular Sciences, 27(14), 6219. https://doi.org/10.3390/ijms27146219
Vancouver
Sakashita K, Kushida Y, Wakao S, Takahashi H, Horibata Y, Okuwaki S, et al. Therapeutic Window for Intravenous Human Muse Cell Administration in Mouse Spinal Cord Injury. International Journal of Molecular Sciences. 2026;27(14):6219. doi:10.3390/ijms27146219
BibTeX
@article{Sakashita2026,
author = {Sakashita, Kotaro and Kushida, Yoshihiro and Wakao, Shohei and Takahashi, Hiroshi and Horibata, Yasuhiro and Okuwaki, Shun and Ogata, Yosuke and Nakagawa, Takane and Sunami, Takahiro and Gamada, Hisanori and Shimizu, Tomoaki and Funayama, Toru and Miura, Kousei and Noguchi, Hiroshi and Sugimoto, Hiroyuki and Yamazaki, Masashi and Dezawa, Mari and Koda, Masao},
title = {Therapeutic Window for Intravenous Human Muse Cell Administration in Mouse Spinal Cord Injury},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6219},
doi = {10.3390/ijms27146219}
}
EUVIMED